Awakn Life Sciences Drug Discovery Program Files Patent Application for a New Class of Entactogen-Like Molecules Feb 17, 2022
Awakn Life Sciences’ Professor Celia Morgan Named One Of The Most Influential Women In The Psychedelics Industry Feb 15, 2022
Awakn Life Sciences Files Patent Application for a New Class of Entactogen-Like Molecules to Treat a Broad Range of… Jan 26, 2022
Awakn Life Sciences Announces Positive Results from Phase II A/B Ketamine-Assisted Therapy for Treatment of Alcohol Use… Jan 11, 2022